Page 8 - Base Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Base therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Base Therapeutics Today - Breaking & Trending Today

Why NIO Are Trading Lower By Over 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Antelope Ent Hldgs (NASDAQ:AEHL), AgileThought (NASDAQ:AGIL)

Gainers Axcella Health Inc. (NASDAQ: AXLA) shares climbed 196% to $0.3335 after the company announced it was granted a patent for long COVID fatigue treatment. ....

Missfresh Limited , Lifevantage Corporation , Paul Jacobs , Holdings Inc , Inhibrx Inc , Chico Fas Inc , Agilethought Inc , Caravelle International Group , Nuvasive Inc , Ys Biopharma Co Ltd , Shineco Inc , Nextier Oilfield Solutions , Vinfast Auto Ltd , Gaming Company Inc , Lixiang Education Holding Co Ltd , Neubase Therapeutics Inc , Pulse Biosciences Inc , Fintech Holding Limited , First Light Acquisition Group Inc , Axcella Health Inc , Globalstar Inc , Big Lots Inc , Akso Health Group , Bionexus Gene Lab Corp , Solutions Inc , Secoo Holding Limited ,

FY2023 EPS Estimates for NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Raised by Analyst

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Free Report) – Equities researchers at Chardan Capital increased their FY2023 earnings per share estimates for shares of NeuBase Therapeutics in a research note issued to investors on Wednesday, August 16th. Chardan Capital analyst K. Nakae now forecasts that the company will post earnings per share of ($5.19) for the […] ....

New York , United States , Worth Venture Partners , First Manhattan Co , Royal Bank , Renaissance Technologies , Neubase Therapeutics Inc , Neubase Therapeutics , Free Report , Chardan Capital , Neubase Therapeutic , Base Therapeutics , Venture Partners , Street Corp , First Manhattan , Get Free Report , Neubase Therapeutics Daily , Nasdaq Nbse , Earnings Estimates ,

Pittsburgh's NeuBase Therapeutics targets incurable disease with licensing agreement

Aug. 8—A South Oakland gene therapy company that suspended development work last week to consider operational alternatives is licensing its technology to a new startup that aims to treat an ....

Robert Friedlander , Department Of Neurological Surgery , Helexva Inc , University Of Pittsburgh School Medicine , Neubase Therapeutics Inc , South Oakland , Base Therapeutics , Neurological Surgery , Pittsburgh School , Science And Technology , Natural Sciences , Usiness And Commerce , Contracts And Legal Transactions , License Agreements , Ealth And Wellness , Edical Conditions And Diseases , Reatments And Therapies , Rading Impact Ice Codes Important Corporate Events , Oint Ventures And Strategic Alliances , Ngene Therapeutics , North America , United States ,

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Short Interest Update

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 71,500 shares, a growth of 108.5% from the June 15th total of 34,300 shares. Based on an average trading volume of 72,200 shares, […] ....

New York , United States , Worth Venture Partners , Renaissance Technologies , Royal Bank , First Manhattan Co , Neubase Therapeutics Inc , Neubase Therapeutics Company Profile , Neubase Therapeutics , Get Free Report , Street Corp , Venture Partners , Base Therapeutics , Neubase Therapeutics Daily , Nasdaq Nbse ,

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) Short Interest Down 93.8% in June

NeuBase Therapeutics, Inc. (NASDAQ:NBSE – Free Report) saw a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 34,300 shares, a drop of 93.8% from the May 31st total of 554,800 shares. Based on an average trading volume of 62,600 shares, the short-interest ratio is […] ....

New York , United States , First Manhattan Co , Neubase Therapeutics Inc , Royal Bank , Worth Venture Partners , Renaissance Technologies , Neubase Therapeutics , Free Report , Base Therapeutics , Venture Partners , Street Corp , First Manhattan , Neubase Therapeutics Daily , Nasdaq Nbse ,